Fujimidai Hospital

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Schizophrenia2 trials
• Depression1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Recruiting3 trials

Lead sponsor

• Eli Lilly and Company2 trials
• Bristol-Myers Squibb1 trial

Running trials

• Recruiting

  A Study of Brenipatide in Adult Participants With Schizophrenia

  NCT07410507· Phase 2· Eli Lilly and Company· Source

  Contact: Takafumi Yahoko (principal investigator)

• Recruiting

  A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  NCT07412756· Phase 3· Eli Lilly and Company· Source

  Contact: Takafumi Yahoko (principal investigator)

• Recruiting

  A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia

  NCT06882785· Phase 3· Bristol-Myers Squibb· Source

  Contact: Takafumi Yahoko, Site 0040

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Schizophrenia2 recruiting
• Depression1 recruiting